Provided by Tiger Fintech (Singapore) Pte. Ltd.

Serina Therapeutics, Inc.

6.00
+0.07501.27%
Post-market: 6.000.00000.00%16:04 EDT
Volume:14.00K
Turnover:82.92K
Market Cap:59.80M
PE:-58.15
High:6.15
Open:5.79
Low:5.77
Close:5.93
Loading ...
Jun 10, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 03, 2024

Major Issues Report

Form 8-K - Current report
Apr 17, 2024

Major Issues Report

Form 8-K - Current report
Apr 03, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Apr 01, 2024

Major Issues Report

Form 8-K - Current report
Mar 26, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 22, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2024

Major Issues Report

Form 8-K - Current report
Mar 14, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Feb 14, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Correspondence

Form CORRESP - Correspondence
Feb 06, 2024

Correspondence

Form CORRESP - Correspondence
Jan 19, 2024

Major Issues Report

Form 8-K - Current report